Skip to main content

Find Clinical Trials

Home
Conditions
Newly Diagnosed or Recurrent Metastatic Melanoma Patients

Clinical trial condition

Newly Diagnosed or Recurrent Metastatic Melanoma Patients

Explore clinical trials studying Newly Diagnosed or Recurrent Metastatic Melanoma Patients. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Newly Diagnosed or Recurrent Metastatic Melanoma Patients trial results

Active, Not Recruiting

PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study

NCT01266096

Conditions: Malignant Brain Tumors, Melanoma, Neoplasms, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details